Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphoma

Valentín Ortiz-Maldonado • 10 Apr 2019
EBMT 2019
Leukemia Lymphoma ARI0002H CAR-T
CART19-BE-01

Valentín Ortiz-Maldonado, MD, of Hospital Clinic of Barcelona, Barcelona, Spain talks about the current status of the Phase I CART19-BE-01 pilot study (NCT03144583), which investigates the infusion of ARI-0002 cells in patients with relapsed/refractory CD19+ hematological malignancies. This video was recorded at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Valentín Ortiz-Maldonado

1:26
The major benefits of producing academic CAR T-cells
Valentín Ortiz-Maldonado • 10 Dec 2023
3:03
The impact of salvage and bridging therapy on CAR T-cell therapy outcomes in B-ALL: an ITT analysis
Valentín Ortiz-Maldonado • 10 Dec 2023
2:58
Var-cel shows promise for the treatment of CLL and Richter's transformation
Valentín Ortiz-Maldonado • 10 Dec 2023
2:25
Efficacy of varnimcabtagene autoleucel in patients with R/R BCL with no indication for CAR-T therapy
Valentín Ortiz-Maldonado • 8 Jun 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals